Recombinant IgE (Ligelizumab Biosimilar) antibody

Catalog No. ABIN7487998

The Mammalian Cells Monoclonal anti-IgE (Ligelizumab Biosimilar) antibody has been validated for . It is suitable to detect IgE (Ligelizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IgE (Ligelizumab Biosimilar) antibody (ABIN7487998)

Target: IgE (Ligelizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IgE (Ligelizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IgE (Ligelizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Ligelizumab Biosimilar - Anti-IGHE mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IgE (Ligelizumab Biosimilar)

Target: IgE (Ligelizumab Biosimilar)

Alternative Name: IGHE (Ligelizumab Biosimilar)

Target Type: Biosimilar

Background: CL-2C